Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB(1)) receptors are potent analgesics devoid of tolerance

類似資料

• Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK(2)) receptors by novel bivalent ligands
  著者:: Zheng, Yaguo, 等
  出版事項: (2009)
• An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligands
  著者:: Yekkirala, Ajay S., 等
  出版事項: (2013)
• A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance
  著者:: Dutta, Raini, 等
  出版事項: (2018)
• Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia
  著者:: Lunzer, Mary M., 等
  出版事項: (2007)
• The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids
  著者:: Speltz, Rebecca, 等
  出版事項: (2020)